Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Incremental cost-effectiveness ratios (ICERs): the silence of the lambdaSocial science & medicine (1982), 2006-05, Vol.62 (9), p.2091-2100 [Peer Reviewed Journal]ISSN: 0277-9536 ;EISSN: 1873-5347 ;DOI: 10.1016/j.socscimed.2005.10.023 ;PMID: 16325975Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?Social science & medicine (1982), 2006-02, Vol.62 (4), p.858-865 [Peer Reviewed Journal]ISSN: 0277-9536 ;EISSN: 1873-5347 ;DOI: 10.1016/j.socscimed.2005.07.001 ;PMID: 16099574Digital Resources/Online E-Resources |
|
3 |
Material Type: Article
|
Conducting Discrete Choice Experiments to Inform Healthcare Decision Making: A User’s GuidePharmacoEconomics, 2008, Vol.26 (8), p.661-677 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826080-00004 ;PMID: 18620460Full text available |
|
4 |
Material Type: Article
|
The Burden of Schizophrenia on Caregivers: A ReviewPharmacoEconomics, 2008-01, Vol.26 (2), p.149-162 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2008 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826020-00005 ;PMID: 18198934Full text available |
|
5 |
Material Type: Article
|
The price of innovation: new estimates of drug development costsJournal of health economics, 2003-03, Vol.22 (2), p.151-185 [Peer Reviewed Journal]Copyright 2003 Elsevier Science B.V. ;ISSN: 0167-6296 ;EISSN: 1879-1646 ;DOI: 10.1016/s0167-6296(02)00126-1 ;PMID: 12606142Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Discounting and decision making in the economic evaluation of health-care technologiesHealth economics, 2011-01, Vol.20 (1), p.2-15 [Peer Reviewed Journal]Copyright © 2010 John Wiley & Sons, Ltd. ;2010 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. Jan 2011 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.1612 ;PMID: 21154521 ;CODEN: HEECEZFull text available |
|
7 |
Material Type: Article
|
A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant TuberculosisPharmacoEconomics, 2012, Vol.30 (1), p.63-80 [Peer Reviewed Journal]Adis Data Information BV 2012 ;2015 INIST-CNRS ;COPYRIGHT 2012 Springer ;Copyright Wolters Kluwer Health Adis International Jan 2012 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11595340-000000000-00000 ;PMID: 22070215Full text available |
|
8 |
Material Type: Article
|
Future costs in cost effectiveness analysisJournal of health economics, 2008-07, Vol.27 (4), p.809-818 [Peer Reviewed Journal]ISSN: 0167-6296 ;EISSN: 1879-1646 ;DOI: 10.1016/j.jhealeco.2007.09.011 ;PMID: 18201785Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Economic Burden of Multiple Sclerosis: A Systematic Review of the LiteraturePharmacoEconomics, 2010-01, Vol.28 (5), p.363-379 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11532230-000000000-00000 ;PMID: 20402540Full text available |
|
10 |
Material Type: Article
|
Direct and Indirect Costs of Non-Vertebral Fracture Patients with Osteoporosis in the USPharmacoEconomics, 2010-05, Vol.28 (5), p.395-409 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International May 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11531040-000000000-00000 ;PMID: 20402541Full text available |
|
11 |
Material Type: Article
|
The Cost and Impact of Health Conditions on Presenteeism to Employers: A Review of the LiteraturePharmacoEconomics, 2009-01, Vol.27 (5), p.365-378 [Peer Reviewed Journal]Adis Data Information BV 2009 ;2009 INIST-CNRS ;Copyright Wolters Kluwer Health Adis International May 2009 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200927050-00002 ;PMID: 19586075Full text available |
|
12 |
Material Type: Article
|
Time-driven activity-based costing in an outpatient clinic environment: development, relevance and managerial impactHealth policy (Amsterdam), 2009-10, Vol.92 (2-3), p.296-304 [Peer Reviewed Journal]ISSN: 0168-8510 ;EISSN: 1872-6054 ;DOI: 10.1016/j.healthpol.2009.05.003 ;PMID: 19505741Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Equivalence of two healthcare costing methods: bottom-up and top-downHealth economics, 2009-10, Vol.18 (10), p.1188-1201 [Peer Reviewed Journal]Copyright © 2008 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. Oct 2009 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.1422 ;PMID: 19097041 ;CODEN: HEECEZFull text available |
|
14 |
Material Type: Article
|
Precision and accuracy in measuring absence from work as a basis for calculating productivity costs in The NetherlandsSocial science & medicine (1982), 2000-07, Vol.51 (2), p.243-249 [Peer Reviewed Journal]2000 Elsevier Science Ltd ;2000 INIST-CNRS ;Copyright Pergamon Press Inc. Jul 2000 ;ISSN: 0277-9536 ;EISSN: 1873-5347 ;DOI: 10.1016/S0277-9536(99)00452-9 ;PMID: 10832571 ;CODEN: SSMDEPFull text available |
|
15 |
Material Type: Article
|
Challenges in Health State Valuation in Paediatric Economic Evaluation: Are QALYs Contraindicated?PharmacoEconomics, 2011-08, Vol.29 (8), p.641-652 [Peer Reviewed Journal]Adis Data Information BV 2011 ;2015 INIST-CNRS ;COPYRIGHT 2011 Wolters Kluwer Health, Inc. ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11591570-000000000-00000 ;PMID: 21604821Full text available |
|
16 |
Material Type: Article
|
Cost Effectiveness of Donepezil in the Treatment of Mild to Moderate Alzheimer’s Disease: A UK Evaluation Using Discrete-Event SimulationPharmacoEconomics, 2010-01, Vol.28 (5), p.411-427 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;Copyright Wolters Kluwer Health Adis International May 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11531870-000000000-00000 ;PMID: 20402542Full text available |
|
17 |
Material Type: Article
|
The Impact of Influenza on Working Days Lost: A Review of the LiteraturePharmacoEconomics, 2008-01, Vol.26 (11), p.911-924 [Peer Reviewed Journal]Adis Data Information BV 2008 ;2009 INIST-CNRS ;COPYRIGHT 2008 Springer ;Copyright Wolters Kluwer Health Adis International 2008 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/00019053-200826110-00004 ;PMID: 18850761Full text available |
|
18 |
Material Type: Article
|
Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006PharmacoEconomics, 2012-04, Vol.30 (4), p.323-336 [Peer Reviewed Journal]Springer International Publishing AG 2012 ;2015 INIST-CNRS ;COPYRIGHT 2012 Springer ;Copyright Wolters Kluwer Health Adis International Apr 2012 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11589470-000000000-00000 ;PMID: 22379953Full text available |
|
19 |
Material Type: Article
|
Accounting for future costs in medical cost-effectiveness analysisJournal of health economics, 1997-02, Vol.16 (1), p.33-64 [Peer Reviewed Journal]1997 ;Copyright Elsevier Sequoia S.A. Feb 1997 ;ISSN: 0167-6296 ;EISSN: 1879-1646 ;DOI: 10.1016/S0167-6296(96)00507-3 ;PMID: 10167344Full text available |
|
20 |
Material Type: Article
|
Should the consumption of survivors be included as a cost in cost-utility analysis?Health economics, 2004-05, Vol.13 (5), p.417-427 [Peer Reviewed Journal]Copyright © 2003 John Wiley & Sons, Ltd. ;Copyright 2003 John Wiley & Sons, Ltd. ;Copyright Wiley Periodicals Inc. May 2004 ;ISSN: 1057-9230 ;EISSN: 1099-1050 ;DOI: 10.1002/hec.850 ;PMID: 15127422Full text available |